Albemarle price target raised to $325 from $315 at BMO Capital

BMO Capital analyst Joel Jackson raised the firm’s price target on Albemarle to $325 from $315 and keeps an Outperform rating on the shares. The company’s Q4 update was "relatively uneventful" and "immaterial" as all guidance numbers from the late January investor event were reiterated, the analyst tells investors in a research note. The firm adds however that even if lithium prices normalize, there’s sufficient upside in the stock as Albemarle is well-positioned to benefit from sizable mid-term lithium/EV demand growth.